Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

News Industry News

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

June 06, 2016

News Industry News

CVRx® Announces Expedited Access Pathway Designation By FDA for Barostim Therapy® for the Treatment Of Heart Failure In Order To Accelerate Access for US Patients

November 18, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.